In NSCLC patients, numerous studies concluded that preoperative or postoperative high CTCs count suggested the shorter lifetime of patients than those with low count [11, 12, 30] and EGFR+ CTCs could predict the high risk of early recurrence after operation [31]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.